Cosmos Health INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE 13D/A: Cosmos Health CEO Grigorios Siokas Boosts Stake to 22.9% Through Debt-to-Equity Conversions
Cosmos Health Inc. CEO Grigorios Siokas has increased his beneficial ownership in the company to 22.9% through a series of debt-to-equity exchange agreements, converting approximately $745,000 of company debt into common stock.
NASDAQ
SCHEDULE 13D/A: Cosmos Health CEO Grigorios Siokas Boosts Stake to 16.6% Through Debt-for-Equity Conversions
Cosmos Health Inc. CEO Grigorios Siokas has increased his beneficial ownership in the company to 16.6% through a series of debt-for-equity exchange agreements, as detailed in a recent Schedule 13D amendment.
NASDAQ
SCHEDULE 13D/A: Cosmos Health CEO Grigorios Siokas Boosts Stake to 17% Through Debt-to-Equity Conversions
Cosmos Health Inc.'s CEO, Grigorios Siokas, has increased his beneficial ownership to 17% of the common stock through a series of debt-to-equity exchange agreements, converting $455,000 of company debt into shares.